Download Audit support - clinical and organisational criteria

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Infection control wikipedia , lookup

Forensic epidemiology wikipedia , lookup

Public health genomics wikipedia , lookup

Lumbar puncture wikipedia , lookup

Transcript
Bacterial meningitis and
meningococcal septicaemia
Audit support
(Clinical and organisational
criteria)
Implementing NICE guidance
(
First issued 2010
Updated 2012
NICE clinical guideline 102
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 1 of 19
This audit support accompanies the clinical guideline: ‘Bacterial meningitis and
meningococcal septicaemia: management of bacterial meningitis and
meningococcal septicaemia in children and young people younger than 16 years in
primary and secondary care’ (available online at
www.nice.org.uk/guidance/CG102).
Issue date: 2010
Updated 2012 to include reference to the NICE quality standard on bacterial
meningitis and meningococcal septicaemia in children and young people.
This is a support tool for clinical audit based on the NICE guidance.
It is not NICE guidance.
Implementation of this guidance is the responsibility of local commissioners and/or
providers. Commissioners and providers are reminded that it is their responsibility
to implement the guidance, in their local context, in light of their duties to avoid
unlawful discrimination and to have regard to promoting equality of opportunity.
Nothing in this guidance should be interpreted in a way which would be inconsistent
with compliance with those duties.
National Institute for Health and Clinical Excellence
Level 1A, City Tower, Piccadilly Plaza, Manchester M1 4BT;; www.nice.org.uk
© National Institute for Health and Clinical Excellence, 2012. All rights reserved. This
material may be freely reproduced for educational and not-for-profit purposes. No
reproduction by or for commercial organisations, or for commercial purposes, is allowed
without the express written permission of NICE.
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 2 of 19
Using audit support
The audit support document can be used to measure current practice in the
management of children and young people under 16 with bacterial meningitis and
meningococcal septicaemia against the recommendations in the NICE guideline.
Use it for a local audit project, by either using the whole tool or cutting and pasting
the relevant parts into a local audit template.
Audit criteria and standards are based on the guideline’s recommendations. The
audit standards given are typically 100% or 0%. If these are not achievable in the
short term, set a more realistic standard based on discussions with local clinicians.
However, the audit standards given remain the ultimate objective.
The data collection tool can be used or adapted for the data collection part of the
clinical audit cycle by the trust, service or practice. The tool is based on the
recommendations relating to clinical activity and on organisational priorities. Data
may be required from a range of sources, including policy documents and patient
records. Suggestions for these are indicated on the tools, although this is not an
exhaustive list and they may differ in your organisation.
The sample for this audit should include children and young people under 16 with a
suspected or actual diagnosis of bacterial meningitis or meningococcal
septicaemia. Select an appropriate sample in line with your local clinical audit
strategy.
Whether or not the audit results meet the audit standards, re-auditing is a key part
of the audit cycle. If your first data collection shows room for improvement, re-run it
once changes to the service have had time to make an impact. Continue with this
process until the results of the audit meet the standards.
Links with other clinical audit priorities
The audit based on this guideline should be considered in conjunction with other
clinical audit priorities such as:
Fever in children audit
Child Health confidential enquiry that includes a themed confidential case review.
Paediatric Intensive Care audit
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 3 of 19
Clinical criteria for ‘Bacterial meningitis and
meningococcal septicaemia’
Symptoms, signs and initial assessment
Children and young people with suspected bacterial meningitis should
have the following monitored and recorded at least hourly:
Criterion 1
Guideline reference

physiological observations of heart rate

respiratory rate

oxygen saturations

blood pressure

temperature

perfusion (capillary refill)

neurological assessment
1.1.6
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 2.
Exceptions
None
Audit standard
100%
Definitions
An example of neurological assessment would be the Alert, Voice, Pain,
Unresponsive (AVPU) scale.
Management in the pre-hospital setting
Criterion 2
Children and young people with suspected bacterial meningitis or
suspected meningococcal septicaemia in pre-hospital settings should be
transferred to secondary care as an emergency by telephoning 999
Guideline reference
1.2.1 (key priority)
Exceptions
None
Audit standard
100%
Definitions
Healthcare professionals will occasionally encounter children and young
people with signs and symptoms suggestive of bacterial meningitis or
meningococcal disease. Any child or young person identified with suspected
bacterial meningitis or meningococcal disease in a pre-hospital setting should
be transferred to secondary care urgently. This will often involve contacting
emergency ambulance services (calling 999) to arrange transport, and
communicating essential clinical information (for example, relevant past
medical history, medications, and drug allergies) to hospital-based medical
teams, usually via telephone.
Diagnosis in secondary care – polymerase chain reaction
Criterion 3
EDTA (ethylenediaminetetraacetic acid) whole blood samples should be
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 4 of 19
submitted for real-time PCR testing to confirm the diagnosis of
suspected meningococcal disease.
Guideline reference
1.3.8
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 7.
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 4
Children and young people with suspected meningococcal disease
should have an EDTA whole blood sample taken as soon as possible
after admission.
Guideline reference
1.3.9
Exceptions
None
Audit standard
100%
Definitions
The guidance states that the blood sample should be taken as soon as
possible after admission because early samples are more likely to be positive
Criterion 5
CSF should be submitted to the laboratory to hold for PCR testing for N
meningitidis and S pneumoniae, but PCR testing should only be
performed if the CSF culture is negative.
Guideline reference
1.3.12
Exceptions
None
Audit standard
100%
Definitions
None
The following diagnostic tools should not be used when investigating for
possible meningococcal disease in children and young people:
Criterion 6

skin scrapings

skin biopsies

aspirates
Guideline reference
1.3.14
Exceptions
None
Audit standard
100%
Definitions
Aspirates are defined as samples aspirated with a needle and syringe form a
petechial/purpuric skin lesion.
Diagnosis in secondary care – lumbar puncture
Criterion 7
Children and young people with suspected bacterial meningitis or
suspected meningococcal septicaemia should have a lumbar puncture
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 5 of 19
performed unless any of the following contraindications are present:

Guideline reference
signs suggesting raised intracranial pressure

reduced or fluctuating level of consciousness

relative bradycardia and hypertension

focal neurological signs

abnormal posture or posturing

unequal, dilated or poorly responsive pupils

papilloedema

abnormal ‘doll’s eye’ movements

shock (see Table 1)

extensive or extending purpura

after convulsions until stabilised

coagulation abnormalities

coagulation results (if obtained) outside the normal range

platelet count below 100 x 109/litre

receiving anticoagulant therapy

local superficial infection at potential lumbar puncture site

respiratory insufficiency
1.3.15, 1.3.18
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 5.
Exceptions
None
Audit standard
100%
Definitions
If contraindications exist at presentation consider delaying lumbar puncture
until there are no longer contraindications. Delayed lumber puncture is
especially worthwhile if there is diagnostic uncertainty or unsatisfactory clinical
progress. Lumbar puncture is considered to have a high risk or precipitating
respiratory failure in the presence of respiratory insufficiency.
Criterion 8
Guideline reference
Lumbar puncture results should be made available within 4 hours.
1.3.20
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 6.
Exceptions
None
Audit standard
100%
Definitions
Lumbar puncture results are defined as white blood cell count, protein and
glucose. These results should be made available to support clinical decision
making with regard to adjunctive steroid therapy.
Criterion 9
In children and young people with suspected bacterial meningitis, a
cranial computed tomography (CT) scan should not be used.
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 6 of 19
Guideline reference
1.3.27, 1.3.28
Exceptions
A – Where a child or young person has a reduced or fluctuating level of
consciousness (Glasgow Coma Score less than 9 or a drop of 3 or more) or
has focal neurological signs, and a CT scan is performed to detect other
possible intracranial pathologies.
Audit standard
100%
Definitions
In children and young people with suspected bacterial meningitis, use clinical
assessment and not a cranial CT scan to decide whether it is safe to perform a
lumbar puncture. CT is unreliable for identifying raised intracranial pressure.
In children and young people with suspected bacterial meningitis who have a
reduced or fluctuating level of consciousness (Glasgow Coma Score less than
9 or a drop of 3 or more) or with focal neurological signs, perform a CT scan to
detect other possible intracranial pathologies.
If performing a CT scan, consult an anaesthetist, paediatrician or intensivist.
Management in secondary care – fluids for bacterial meningitis
Criterion 10
Children and young people with suspected or confirmed bacterial
meningitis should not have fluids restricted.
Guideline reference
1.4.23
Exceptions
B – Where there is evidence of raised intracranial pressure.
C – Where there is evidence of increased antidiuretic hormone (ADH)
secretion.
Audit standard
100%
Definitions
Full-volume fluid maintenance fluids should be given to children and young
people with suspected or confirmed bacterial meningitis to avoid
hypoglycaemia and to maintain electrolyte balance.
The National Patient Safety Agency (NPSA) has highlighted that some acutely
ill children with increased ADH secretion may benefit from maintenance fluid
being restricted (Please see ‘Reducing the risk of hyponatraemia when
administering intravenous infusions to children’ [NPSA/2007/22] for more
details; available at http://www.npsa.nhs.uk).
Criterion 11
Children and young people with suspected or confirmed bacterial
meningitis should have fluid administration and urine output monitored.
Guideline reference
1.4.27
Exceptions
None
Audit standard
100%
Definitions
This is to ensure adequate hydration and avoid overhydration.
Criterion 12
Children and young people with suspected or confirmed bacterial
meningitis should have electrolytes and blood glucose monitored
regularly.
Guideline reference
1.4.28
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 7 of 19
Exceptions
None
Audit standard
100%
Definitions
The guidance states that electrolytes and blood glucose should be monitored
at least daily while the person is receiving intravenous fluids.
Long-term management
Criterion 13
Children and young people who have had bacterial meningitis or
meningococcal septicaemia should be offered an audiological test as
soon as possible.
Guideline reference
1.5.3
Exceptions
None
Audit standard
100%
Definitions
The guidance states that the test should be performed as soon as possible,
preferably before discharge, within 4 weeks of being fit to test.
This is in line with recommendations in the National Deaf Children's Society
(NDCS) (2009) Quality Standards in Paediatric Audiology, Vol IV.
Criterion 14
Children and young people who are found to have severe or profound
deafness should be offered an urgent assessment for cochlear implants
as soon as they are fit to undergo testing.
Guideline reference
1.5.4
Exceptions
None
Audit standard
100%
Definitions
Further guidance on the use of cochlear implants for severe to profound
deafness can be found in ‘Cochlear implants for severe to profound deafness
in children and adults’ [NICE technology appraisal 166].
Criterion 15
Children and young people who have had bacterial meningitis or
meningococcal septicaemia should be reviewed by a paediatrician 4–6
weeks after discharge from hospital.
Guideline reference
1.5.5 (key priority)
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 14.
Exceptions
None
Audit standard
100%
Definitions
The purpose of this review should be to discuss morbidities associated with
the child’s condition and obtain referral to the appropriate services. The review
should take place with the results of their hearing test. The following
morbidities should be specifically considered:

hearing loss (with the child or young person having undergone an
urgent assessment for cochlear implants as soon as they are fit)

orthopaedic complications (damage to bones and joints)

skin complications (including scarring from necrosis)
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 8 of 19

psychosocial problems

neurological and developmental problems

renal failure.
The following professionals should be informed of the child or young
person’s bacterial meningitis or meningococcal septicaemia:
Criterion 16

GP

health visitor

school nurse.
Guideline reference
1.5.6
Exceptions
D – Where the school nurse has not been notified because the child or young
person is not of school age.
Audit standard
100%
Definitions
None
Criterion 17
Children and young people should be tested for complement deficiency
if they have had more than one episode of meningococcal disease, or
one episode of meningococcal disease caused by serogroups other than
B, or meningococcal disease caused by any serogroup and a history of
other recurrent or serious bacterial infections.
Guideline reference
1.5.8
Exceptions
None
Audit standard
100%
Definitions
Serogroups listed in the full guidance include C, A, X, Y, W135, Z, 29E and
non-groupable.
Do not test children and young people for complement deficiency who have
had either meningococcal disease caused by serogroup B meningococcus or
unconfirmed meningococcal disease (1.5.10).
Number of criterion
replaced:
Local alternatives to above criteria (to be used where other data
addressing the same issue are more readily available).
Exceptions
Settings
Audit standard
Definitions
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 9 of 19
Organisational criteria for ‘Bacterial meningitis and
meningococcal septicaemia’
Criterion 18
Table 1 in the NICE guideline should be used to identify children and
young people who have bacterial meningitis or meningococcal
septicaemia.
Guideline reference
1.1.1 (key priority)
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 19
Healthcare professionals should be trained in the recognition and
management of meningococcal disease.
Guideline reference
1.1.7 (key priority)
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 20
National or local protocols should be used for the management of
seizures in children and young people with suspected bacterial meningitis
or meningococcal septicaemia.
Guideline reference
1.4.19
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 21
National or local protocols should be used to treat raised intracranial
pressure in children and young people with suspected bacterial
meningitis.
Guideline reference
1.4.20
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 22
National or local protocols should be used for the administration of
vasoactive agents in children and young people with suspected or
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 10 of 19
confirmed bacterial meningitis or meningococcal septicaemia.
Guideline reference
1.4.32
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 23
National or local protocols should be used for intubation in children and
young people with suspected or confirmed bacterial meningitis or
meningococcal septicaemia.
Guideline reference
1.4.38
Exceptions
None
Audit standard
100%
Definitions
None
Criterion 24
Paediatric intensive care units (PICUs) should have paediatric intensive
care retrieval teams to undertake the transfer of children and young
people.
Guideline reference
1.4.50
Associated quality standard: Bacterial meningitis and meningococcal
septicaemia in children and young people statement 11.
Exceptions
None
Audit standard
100%
Definitions
Retrieval teams should comprise of medical and nursing staff.
Number of criterion
replaced:
Local alternatives to above criteria (to be used where other data
addressing the same issue are more readily available).
Exceptions
Audit standard
Definitions
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 11 of 19
Patient data collection tool for ‘bacterial meningitis
and meningococcal septicaemia’
Complete one form for each patient or episode.
Patient identifier:
Sex:
Age:
Data
item
Criteria
no.
Symptoms, signs and initial assessment
No.
Ethnicity:
Yes
No
NA/
Exceptionsa
NICE
guideline ref.
Did the child or young person with suspected bacterial
meningitis have the following monitored and recorded
at least hourly?



physiological observations of heart rate
respiratory rate
oxygen saturations
1.4



blood pressure
temperature
perfusion (capillary refill)
1.5

neurological assessment
1.1
1
1.2
1.3
1.1.6
Management in the pre-hospital setting
2
2.1
In a pre-hospital setting, was the child or young
person with suspected bacterial meningitis or
suspected meningococcal septicaemia transferred to
secondary care as an emergency by phoning 999?
1.2.1
Diagnosis in secondary care – polymerase chain reaction
3
3.1
Was the EDTA whole blood sample submitted for realtime PCR testing to confirm the diagnosis of
suspected meningococcal disease?
1.3.8
4
4.1
Did the child or young person with suspected
meningococcal disease have an EDTA whole blood
sample taken as soon as possible after admission?
1.3.9
5.1
Was the CSF submitted to the laboratory to hold for
PCR testing for N meningitidis and S pneumoniae?
5
1.3.12
5.2
Was the PCR test was only performed if the CSF
culture was negative?
Were the following diagnostic tools used for the
diagnosis of meningococcal disease in the child or
young person:
6
6.1

skin scrapings
6.2

skin biopsies
6.3

aspirates
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 12 of 19
1.3.4
No.
Data
item
no.
Criteria
Yes
No
NA/
Exceptionsa
NICE
guideline ref.
Diagnosis in secondary care – lumbar puncture
7.1
Did the child or young person with suspected bacterial
meningitis or suspected meningococcal septicaemia
have a lumbar puncture performed?
If not, which of the following contraindications were
given as reasons?


reduced or fluctuating level of
consciousness
7.3

relative bradycardia and hypertension
7.4

focal neurological signs
7.5

abnormal posture or posturing

unequal, dilated or poorly responsive
pupils
7.7

papilloedema
7.8

abnormal ‘doll’s eye’ movement
7.2
7.6
7
signs suggesting raised intracranial pressure
7.9

shock (see Table 1)
7.10

extensive or extending purpura
7.11

after convulsions until stabilised

coagulation abnormalities

coagulation results (if obtained) outside
the normal range
7.13

platelet count below 100 x 109/litre
7.14

receiving anticoagulant therapy
7.12
7.15
7.16


1.3.15, 1.3.18
local superficial infection at potential lumbar
puncture site
respiratory insufficiency
7.17
Was a delayed lumbar puncture eventually carried
out?
8
8.1
Were the lumbar puncture results available within 4
hours?
9
9.1
Was a cranial CT scan used in the child or young
person with suspected bacterial meningitis?
1.3.20
A
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 13 of 19
1.3.27, 1.3.28
No.
Data
item
no.
Criteria
Yes
No
NA/
Exceptionsa
NICE
guideline ref.
Management in secondary care – fluids for bacterial meningitis
10
11
12
10.1
Did the child or young person with suspected or
confirmed bacterial meningitis have fluids restricted?
11.1
Did the children or young person with suspected or
confirmed bacterial meningitis have fluid
administration and urine output monitored?
1.4.27
12.1
During the acute phase of their illness, did the child or
young person with suspected or confirmed bacterial
meningitis have electrolytes and blood glucose
monitored daily?
1.4.28
B/C
1.4.23
Long-term management
13
13.1
Has the child or young person who has had bacterial
meningitis or meningococcal septicaemia been
offered an audiological test within 4 weeks?
1.5.3
14
14.1
Did the child or young person who was found to have
severe or profound deafness offered an assessment
for cochlear implants?
1.5.4
15.1
Has the child or young person who has had bacterial
meningitis or meningococcal septicaemia been
reviewed by a paediatrician 4–6 weeks after discharge
from hospital?
1.5.5
15
Were the following professionals informed of the child
or young person’s bacterial meningitis or
meningococcal septicaemia?
16
16.1

GP
16.2

health visitor
16.3

school nurse
1.5.6
D
Was the child or young person tested for complement
deficiency if they had any of the following?
17
17.1
a Circle

more than one episode of meningococcal
disease

an episode of meningococcal disease caused
by serogroups other than B

meningococcal disease caused by any
serogroup and a history of other recurrent or
serious bacterial infections
1.5.8
exception codes as appropriate. Details of exceptions are listed at the end of the patient data collection tool.
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 14 of 19
Exception codes
A – Where a child or young person has a reduced or fluctuating level of consciousness
(Glasgow Coma Score less than 9 or a drop of 3 or more) or focal neurological signs, and a
CT scan is performed to detect other possible intracranial pathologies.
B – Where there is evidence of raised intracranial pressure
C – Where there is evidence of increased ADH secretion
D – Where the school nurse has not been notified because the child or young person is not of
school age)
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 15 of 19
Organisational data collection tool for ‘bacterial
meningitis and meningococcal septicaemia’
Organisation/service:
Data
item
Criteria
18.1
Do healthcare professionals in your organisation
use table 1 in the NICE guidance to identify
children and young people who have bacterial
meningitis or meningococcal septicaemia (see
Appendix A)?
1.1.1
19.1
Are the healthcare professionals in your
organisation involved in the treatment of children
and young people trained in the recognition and
management of meningococcal disease?
1.1.7
20.1
Does your organisation have national or local
protocols in use for the management of seizures in
children and young people with suspected bacterial
meningitis or meningococcal septicaemia?
1.4.19
21.1
Does your organisation have national or local
protocols in use to treat raised intracranial pressure
in children and young people with suspected
bacterial meningitis?
1.4.20
22.1
Does your organisation have national or local
protocols in use for the administration of vasoactive
agents in children and young people with
suspected or confirmed bacterial meningitis or
meningococcal septicaemia?
1.4.32
23
23.1
Does your organisation have national or local
protocols in use for intubation in children and young
people with suspected or confirmed bacterial
meningitis or meningococcal septicaemia?
1.4.38
24
24.1
Does your PICU have paediatric intensive care
retrieval teams to undertake the transfer of children
and young people?
1.4.50
No.
18
19
20
21
22
Yes
No
NA/
Exceptions a
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 16 of 19
NICE
guideline ref.
Further information
For further information about clinical audit refer to a local clinical audit
professional in your own organisation or the HQIP website.
To ask a question about this audit support, or to provide feedback to help
inform the development of future tools, please email
[email protected]
Supporting implementation
NICE has developed tools to help organisations implement the clinical
guideline on bacterial meningitis and meningococcal septicaemia (listed
below). These are available on our website (www.nice.org.uk/CG102).
 Costing statement.
 Slides highlighting key messages for local discussion.
 Implementation advice on how to put the guidance into practice and
national initiatives that support this locally.
 Audit support for monitoring local practice (this document).
A series of practical guides to implementation are also available on our
website (www.nice.org.uk/usingguidance/implementationtools).
The guidance
You can download the guidance documents from www.nice.org.uk/CG102.
For printed copies of the quick reference guide or ‘Understanding NICE
guidance’, phone NICE publications on 0845 003 7783 or email
[email protected] and quote N2201 (quick reference guide) and/or
N2202 (‘Understanding NICE guidance’).
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 17 of 19
Appendix A
Table 1 Symptoms and signs of bacterial meningitis and
meningococcal septicaemia
Symptom/sign
Fever
Vomiting/nausea
Lethargy
Irritable/unsettled
Ill appearance
Refusing
food/drink
Headache
Muscle ache/joint
pain
Respiratory
symptoms/signs
or breathing
difficulty
Chills/shivering
Diarrhoea,
abdominal
pain/distension
Sore
throat/coryza or
other ear, nose
and throat
symptoms/signs
Bacterial
Meningococcal Meningococcal Notes
meningitis
disease
septicaemia
(meningococcal (meningococcal
meningitis and
meningitis
meningitis
and/or
caused by
meningococcal
other bacteria)
septicaemia)
Common non-specific symptoms/signs



Not always
present,
especially in
neonates
























Less common non-specific symptoms/signs





NK

Non-blanching
rash

Stiff neck
Altered mental



More specific symptoms/signs



NK

NK

Be aware that
a rash may be
less visible in
darker skin
tones – check
soles of feet,
palms of
hands and
conjunctivae
Includes
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 18 of 19
state
Capillary refill
time more than 2
seconds
Unusual skin
colour
Shock
Hypotension
Leg pain
Cold hands/feet
Back rigidity
Bulging
fontanelle
confusion,
delirium and
drowsiness,
and impaired
consciousness
NK


NK



NK
NK
NK












NK
NK


Photophobia


Kernig’s sign


Brudzinski’s sign


Unconsciousness


Toxic/moribund
state


Paresis


Focal
neurological
deficit including
cranial nerve
involvement and
abnormal pupils


Seizures
Signs of shock
 Capillary refill time more than 2 seconds
 Unusual skin colour
 Tachycardia and/or hypotension
 Respiratory symptoms or breathing difficulty
 Leg pain
 Cold hands/feet
 Toxic/moribund state
 Altered mental state/decreased conscious level
 Poor urine output
Only relevant
in children
aged under 2
years
X
X
X


X
X
X
 symptom/sign present
X symptom/sign not present
NK not known if a symptom/sign is present (not reported in the evidence)
Audit support: Bacterial meningitis and meningococcal septicaemia (2012) – clinical and
organisational criteria
Page 19 of 19